Under the direction of Dr. Suárez-Calvet, the center will have the creation of a state-of-the-art laboratory focused on the development and validation of new biomarkers and will also analyze blood factors that may have a rejuvenating effect on the brain.
The Pasqual Maragall Foundation and its research center, the Barcelonaβeta Brain Research Center (BBRC), have published the 2020 Activity Report; a collection of the most outstanding information on the scientific, social and economic activity of the two entities.
Within the framework of the Science Festival, Dr. Aleix Sala gave the talk 'From the plate to the brain'
A study led by the BBRC, with the support of the “la Caixa” Foundation, suggests that people at increased risk of developing Alzheimer's experience weight loss that would precede cognitive impairment.
The last drug approved by the FDA was in 2003, and until now any treatment has proved to slow down the progression of the disease.
The researcher of the Clinical Research Group, Biomarkers and Risk Factors of the BBRC will vice-chair the group "Reserve, Resilience and Protective Factors of the International Society to advance research and treatment of Alzheimer’s
The former director of the BBRC's Alzheimer's Prevention Program will occasionally advise the Center's management on issues related to research in the field of Alzheimer's and other neurodegenerative diseases
EURO-FINGERS aims to provide a common framework for multimodal European studies of Alzheimer's dementia prevention, accommodating combinations of interventions on disease risk factors with possible drugs.
A study led by the BBRC has found that people without cognitive problems but with a higher genetic risk of developing Alzheimer's have certain areas of the brain more resilient to the disease if they are accustomed to consuming a nutrient provided by blue fish.